MMedication Read More Table 2.0: Restaurants absorb ‘Ozempic effect’ for weight-loss drug consumersFebruary 23, 2026 New Delhi:Dozens of Indian restaurants and cafe chains are fast-tracking Size O menus — the O standing for…
HHealth Read More Mounjaro ingredient shows promise in lowering alcohol consumptionFebruary 21, 2026 For the first time, researchers show that tirzepatide – the active ingredient in the diabetes and weight-loss drug…
HHealth Read More How GLP-1 drugs affect the body beyond weight loss and glucose controlFebruary 19, 2026 Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks,…
MMedication Read More Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasibleFebruary 18, 2026 HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
MMedication Read More New drug CagriSema leads to 14% weight loss in trialFebruary 10, 2026 Share on PinterestNew combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to…
MMedication Read More Health Canada warns of fake semaglutide drugs, cites ‘product safety’ risks – NationalJanuary 23, 2026 Health Canada is warning Canadians of the dangers of buying “fake or unauthorized products” meant to replicate popular…
MMedication Read More What is 'natural Ozempic' – and how good is the science? – The i PaperJanuary 12, 2026 What is ‘natural Ozempic’ – and how good is the science? The i PaperWhat is ‘oatzempic’? Does it actually…
MMedication Read More Skinny’s back on the menu — US FDA approves Novo Nordisk’s oral weight-loss drugDecember 30, 2025 WASHINGTON, Dec 23 — The US Food and Drug Administration approved Novo Nordisk’s weight-loss pill on Monday, giving…
MMedication Read More Eli Lilly Drug Retatrutide Clinical Trial ResultsDecember 17, 2025 Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become…
MMedication Read More Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event riskNovember 29, 2025 1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
HHealthcare Read More Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mgNovember 26, 2025 If approved, investigational semaglutide 7.2 mg injection would offer the optionality of a higher dose for greater weight…
HHealth Read More Searches for “Ozempic face” surge as people look for filler-based solutionsNovember 21, 2025 New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…